title: Gadofosveset-enhanced magnetic resonance angiography as a means of evaluating pulmonary arteriovenous malformation: a case report.
abstract: This case report is a unique presentation of a new potential indication for Gadofosvest (Ablavar), a blood pool contrast agent for magnetic resonance angiography (MRA). Ablavar is an excellent MRA contrast agent because it provides optimal contrast opacification of both the arterial and venous system, unlike the conventional extracellular agents that are used for arterial imaging only. The present case report demonstrates the ability of Ablavar to demonstrate pulmonary arteriovenous malformation (AVM), showing both its arterial feeders as well as its venous drainage tract.
authors.affiliation: Montreal Heart Institute, Montreal, Canada. josephine.pressacco@icm-mhi.org
authors.forename: Josephine
authors.initials: J
authors.lastname: Pressacco
authors.forename: Konstantin
authors.initials: K
authors.lastname: Papas
mesh_terms: D000328:Adult; D001165:Arteriovenous Malformations / Q000175:diagnosis* / Q000000981:diagnostic imaging; D003287:Contrast Media; D005260:Female; D005682:Gadolinium; D006801:Humans; D033162:Incidental Findings; D018810:Magnetic Resonance Angiography; D009942:Organometallic Compounds; D011651:Pulmonary Artery / Q000002:abnormalities*; D011667:Pulmonary Veins / Q000002:abnormalities*; D011859:Radiography; D055815:Young Adult
chemical_list: D003287:Contrast Media; D009942:Organometallic Compounds; D005682:Gadolinium; C109932:gadofosveset trisodium